# Efavirenz for Patients With Alzheimer's Disease

> **NCT03706885** · PHASE1 · COMPLETED · sponsor: **Case Western Reserve University** · enrollment: 5 (actual)

## Conditions studied

- Alzheimer Disease, Early Onset

## Interventions

- **DRUG:** Sustiva Pill

## Key facts

- **NCT ID:** NCT03706885
- **Lead sponsor:** Case Western Reserve University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-05
- **Primary completion:** 2022-01-28
- **Final completion:** 2022-01-28
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-02-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03706885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03706885, "Efavirenz for Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03706885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*